According to court documents, the lawsuits focus on Moderna's use of lipid nanoparticle encapsulation of mRNA vaccines, a technology used to protect the mRNA molecules as they are delivered to ...
Meanwhile, Alnylam has filed suit against both Pfizer/BioNTech and Moderna in the US, alleging that both their vaccines infringe patents it holds on lipid nanoparticles used to deliver them in the ...
The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides & Proteins, Monoclonal Antibodies ...
Imagine if antibodies, hormones for fertility, proteins like insulin, and vaccines could be swallowed instead of taken by ...
Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...
A novel strategy using lipid nanoparticles to reprogram liver immunity shows promise in generating antitumor responses ...
Publication information: “Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity,” from Cell Reports Medicine ...